MREO: the cash flow

MyFinsight

For the quarter ending 2026-03-31, MREO had -$4,612K decrease in cash & cash equivalents over the period. -$4,312K in free cash flow.

Cash Flow	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Net loss	-6,719	-7,351	-7,024	-27,503
Share-based compensation	1,605	1,543	1,712	4,343
Depreciation	44	36	39	82
Amortization of intangible assets	127	424	-183	224
Amortization of operating lease right-of-use assets	134	132	133	262
Change in fair value of warrants	-17	-294	-196	-315
Non-cash interest income	31	70	34	-
Non-cash interest expense	12	18	17	193
Foreign currency transaction gain/(loss)	1,628	-126	1,873	-8,091
Other income	-	0	300	-
Non-cash consideration, milestone payment	-	0	-	-
Prepaid expenses and other current assets	-271	-235	164	155
Research and development incentives receivable	95	473	-1,661	-208
Accounts payable	1,957	447	-236	-1,589
Accrued expenses and other liabilities	229	-2,261	-673	540
Operating lease liabilities	-201	-194	-188	-361
Net cash used in operating activities	-4,312	-7,682	-7,309	-15,980
Payments for intangible assets	300	0	0	300
Purchase of property and equipment	0	0	0	20
Proceeds from out-licensing	-	0	300	-
Net cash used in investing activities	-300	0	300	-320
Proceeds from exercise of warrants	0	0	0	487
Proceeds from issuance of ordinary shares	-	39	0	0
Transaction costs on issuance of ordinary shares	0	0	0	199
Net cash provided by financing activities	0	39	0	288
Decrease in cash and cash equivalents	-4,612	-7,643	-7,009	-16,012
Cash and cash equivalents at january 1,	40,992	21,104	69,802	-
Effect of exchange rate changes	-157	-63	1,917	-
Cash and cash equivalents at march 31,	36,223	-7,706	48,698	-

Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.